Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2023

May 3, 2023

284_dirs_2023-05-03_9b7cf3f4-80ef-47ed-9443-a23d88066d40.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2023-05-01

Reporting Person: Karachun Rita A (Sr. VP Fince-Global Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-05-01 Common Stock M 930 $115.47 Acquired 44878.972 Direct
2023-05-01 Common Stock F 319 $115.47 Disposed 44559.972 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-05-01 Restricted Stock Unit $ M 930 Disposed 2023-05-01 Common Stock (930) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.